Header

Presented by : IMMUNOTEC

Select Language

Search Immunotec

Press Releases


Click one of the following links to read one of Immunotec's press releases.

 2011
 12/29/11  Immunotec mourns the death of Dr. Gustavo Bounous
09-15-2011  Immunotec Announces Closing of $3.45M of New Financing
 09-09-11  Immunotec Announces Financial Results for the Third Quarter Ended July 31, 2011 and changes to its Board.
 08-03-11
 
  Immunotec appoints Mr. Daniel Audet as Vice-President of Marketing
 06-17-11

Immunotec Announces Financial Results for the Second Quarter Ended April 30, 2011

05-24-11

IMMUNOTEC Signs Material Contract with Glanbia Nutritionals

03-25-11

 Q1-2011 - Period Ended January 31, 2011

02-21-11

Immunotec Announces Financial Results for the Year Ended October 31, 2010

01-24-11

Immunotec Welcomes New President

2010
01-24-11  Immunotec Welcomes New President
 12-22-10  Immunotec mourns passing of Senior VP - Dr Wulf Dröge
 12-09-10  Immunotec CEO to retire at the end of the year
11-12-10  Immunotec announces Stock Option Grant
09-17-10 Q3-2010 - Period ended July 31, 2010
09-07-10  Immunotec announces changes to Management
08-24-10 Immunotec Appoints New Executive Chairman of the Board
08-10-10 Immunotec mourns passing of Chairman Alex Konigsberg
06-21-10 Q2-2010 - Period Ended April 30, 2010
06-16-10 Immunotec to Present at the World Cancer Congress Conference In Singapore
 05-13-10  Immunotec Announces Closing of Previously Announced Transaction
05-03-10 Immunotec Acquires Assets from Licensee in Mexico and Expands its Seamless Network
05-03-10 Immunotec Appoints Robert M. Henry as New Director
03-26-10 Q1-2010 - Period Ended January 31, 2010
02-17-10 Q4-2009 - Year Ended October 31, 2009
2009
12-07-09 Immunotec Announces commencement of IMN 1207 US Lung Cancer Study funded by Moffitt Cancer Center CCOP Research Base
10-01-09 Immunotec appoints Patrick Montpetit as Chief Financial Officer 
09-29-09 Q3-2009 - Period Ended July 31, 2009
08-03-09 Immunotec Announces an Independent, Clinical Research Initiative at Beaumont Hospitals’ Hospital’s Community Clinical Oncology Program (CCOP).
07-31-09 Immunotec Inc. announces the closing of its Korean operations.
07-06-09 IMMUNOTEC announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process.
06-23-09 Q2-2009 - Period Ended April 30, 2009
03-30-09  Election of New Director
03-25-09 Q1-2009 - Period Ended January 31, 2009
02-12-09 Q4-2008 - Year Ended October 31, 2008
2008
10-23-08 Immunotec Congratulates 2008 Nobel Prize Winner in Medicine, Dr. Luc Montagnier
09-24-08 Q3-2008 - Period Ended July 31, 2008
08-28-08 Oral Tolerability of Cysteine-Rich Protein Isolate (Immunocal) in Autism – A Pilot Study
07-03-08 Immunotec Inc. Announces New Chief Operating Officer
06-19-08 Q2-2008 - Period Ended April 30, 2008
03-28-08 Q1-2008 - Period Ended January 31, 2008
02-19-08 Q4-2007 - Year Ended October 31, 2007
01-17-08 Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study
2007
11-13-07 Health Canada approves health claim for Immunocal
10-11-07 Immunotec Inc. announces appointment of President & CEO James A. Northrop
09-27-07 Q3-2007 - Period Ended July 31, 2007
09-26-07 Immunotec Inc. announces retirement of President and CEO C.H. (Chuck) Roberts
06-28-07 Q2-2007 - Period Ended April 30, 2007
04-03-07 Q1-2007 - Period Ended January 31, 2007
01-23-07 Immunotec Inc. to Commence Trading on the TSX Venture Exchange